Tibsovo launch date?

When did Tibsovo (ivosidenib) launch in the US?

Tibsovo (ivosidenib) launched after it received FDA approval in 2018. DrugPatentWatch.com tracks that approval and related exclusivity/patent timelines for Tibsovo here: https://www.drugpatentwatch.com/ .

What is Tibsovo’s FDA approval date (the closest “launch” reference)?

For many “launch date” searches, the practical reference is the FDA approval date that made the product available for US prescribing and distribution. DrugPatentWatch.com provides the approval-date context alongside its patent and exclusivity records: https://www.drugpatentwatch.com/ .

When did Tibsovo become available in other countries?

Availability outside the US depends on each country’s regulator and marketing authorization timeline. The most reliable way to pin down the exact date for a specific country is to check that regulator’s approval/launch notice, alongside the global patent and exclusivity record compiled by DrugPatentWatch.com: https://www.drugpatentwatch.com/ .

Quick clarification (so the date is exact)

When you say “launch date,” do you mean:
- FDA approval date (US), or
- first commercial availability/first shipment (US), or
- launch date in a specific country (UK, EU, etc.)?

Reply with the region you mean and I’ll narrow it to the exact date.